뒤로Microbial Symbioses with Humans: The Human Microbiome and Its Impact
스터디 가이드 - 스마트 노트
자료에 맞춘 맞춤형 노트, 핵심 정의, 예시, 맥락을 확장해 제공합니다.
Microbial Symbioses With Humans
Definitions: Microbiome and Microbiota
The human body hosts a vast array of microorganisms that interact with their host in complex ways. Understanding the terminology is essential for studying these relationships.
Microbiome: The functional collection of different microbes (bacteria, archaea, viruses, fungi) in a particular environmental system, such as the human body. It encompasses not only the organisms but also their genetic material and interactions.
Microbiota: The specific types of organisms present in an environmental habitat, such as human skin or the gastrointestinal (GI) tract.
Example: The skin microbiota includes Staphylococcus and Propionibacterium species, while the gut microbiota is dominated by Bacteroides and Firmicutes.
Methodologies for Probing the Human Microbiome
Metagenomics
Modern techniques have revolutionized the study of the human microbiome, allowing for comprehensive analysis of microbial diversity and abundance.
Metagenomics: The study of genetic material recovered directly from environmental samples, enabling identification of microbial communities without the need for culturing.
Key Steps:
Sample collection (e.g., stool, saliva, skin swab)
DNA extraction and library preparation
DNA sequencing
Sequence analysis and genome reconstruction
Applications: Metagenomics is used to profile the diversity and function of the human microbiome, identify novel organisms, and study microbial interactions.
Overview of the Human Microbiome
Major Microbial Groups by Body Site
The human microbiome varies significantly by anatomical site, with distinct communities adapted to local conditions.
Site | Dominant Genera |
|---|---|
Skin | Propionibacterium, Staphylococcus, Corynebacterium, Anaerococcus |
Saliva | Streptococcus, Prevotella, Veillonella, Haemophilus |
Urogenital Tract | Lactobacillus, Gardnerella, Atopobium |
Gastrointestinal Tract | Bacteroides, Firmicutes, Prevotella, Ruminococcus |
Example: The GI tract is dominated by Bacteroides and Firmicutes, while the urogenital tract is rich in Lactobacillus.
Gastrointestinal Microbiota
Role and Colonization
The gut microbiota plays a crucial role in early development, health, and disease predisposition. Colonization begins at birth and is influenced by delivery mode and diet.
Functions: Digestion, vitamin synthesis, immune system education, and protection against pathogens.
Colonization: Begins at birth, with initial exposure from the mother and environment.
Large Intestine Microbiota
The large intestine acts as an in vivo fermentation vessel, supporting dense microbial populations that metabolize dietary components.
Fermentation: Microbes use nutrients from digested food to produce short-chain fatty acids and other metabolites.
Localization: Most microbes are found in the lumen, with some in mucosal layers.
Bacterial Diversity of Feces
Fecal samples reflect the diversity of gut microbiota, with two major phyla dominating:
Phylum | Representative Families |
|---|---|
Bacteroidetes | Bacteroidaceae, Prevotellaceae, Rikenellaceae |
Firmicutes | Lachnospiraceae, Ruminococcaceae, Clostridiaceae |
Products of Intestinal Microbiota and Immune System Education
Gut microbes contribute to host metabolism and immune function through various biochemical activities.
Product/Process | Function/Enzyme |
|---|---|
Vitamin synthesis | Thiamine, riboflavin, pyridoxine, B12, K |
Amino acid synthesis | Aspartate, glutamate, methionine, tryptophan, lysine |
Gas production | CO2, CH4, H2 |
Organic acid production | Acetic, propionic, butyric, lactic, succinic acids |
Glycosidase reactions | β-glucosidase, α-galactosidase |
Steroid metabolism | Deconjugation, dehydroxylation, oxidation |
Oral Microbiota
Composition and Function
The oral cavity is a complex habitat with diverse microbial communities. Saliva contains antimicrobial enzymes, but nutrient-rich surfaces promote microbial growth.
Major Genera: Streptococcus, Actinomyces, Veillonella, Fusobacterium
Biofilm Formation: Dental plaque is a biofilm that supports fermentative bacteria.
Microbiota of the Respiratory Tract
Upper vs. Lower Respiratory Tract
The respiratory tract is divided into upper and lower regions, with distinct microbial colonization patterns.
Upper Respiratory Tract: Colonized by microbes, most of which are trapped in mucus and expelled or swallowed.
Lower Respiratory Tract: Typically sterile, with no resident microbiota under healthy conditions.
Urogenital Tracts and Their Microbes
Urogenital Tract Microbiota
The urogenital tract has unique microbial communities and is influenced by physiological and environmental factors.
Kidneys: Typically sterile in both males and females.
Urethra: Can harbor potential pathogens such as Escherichia coli and Proteus mirabilis under altered conditions (e.g., pH changes).
Vaginal Microbiota
The adult female vagina is weakly acidic (pH ~5) and contains glycogen, supporting specific microbial populations.
Lactobacillus acidophilus: Ferments glycogen to produce lactic acid, maintaining an acidic environment that inhibits pathogens.
Skin Microbiota
Factors Influencing Skin Microbiota
The skin's microbial composition is shaped by its chemical and physical properties, as well as environmental factors.
Microenvironments: Dry skin, moist skin, and sebaceous (oily) skin each support different microbial communities.
Major Genera: Propionibacterium, Staphylococcus, Corynebacterium
Colonization, Succession, & Stability of Gut Microbiota
Influence of Birth and Diet
Early life events shape the gut microbiome, with lasting effects on health.
Vaginal vs. Cesarean Birth: Vaginally delivered infants acquire microbiota resembling the mother's vaginal flora, while C-section infants have more skin-associated microbes.
Breast Milk vs. Formula: Breastfed infants develop a distinct gut microbiome compared to formula-fed infants, influenced by human milk oligosaccharides.
Disorders Attributed to Gut Microbiota
Inflammatory Bowel Disease (IBD)
IBD is associated with chronic gut inflammation and microbial imbalance (dysbiosis).
Dysbiosis: Disruption of normal microbiota homeostasis.
Risk Factors: Early antibiotic use increases IBD risk; IBD patients have lower microbiome diversity.
Gut Microbiota and Obesity
Microbial composition influences host metabolism and obesity risk.
Mouse Models: Germ-free mice have less body fat than normal mice; genetically obese mice have distinct microbiota.
Humans: Obese individuals have higher levels of Prevotella and methanogens.
Disorders Attributed to Oral Microbiota
Dental Caries and Periodontitis
Oral biofilms composed of fermenting bacteria can lead to dental caries and periodontal disease.
Dental Caries: Acid production by fermenters erodes tooth enamel.
Periodontal Disease: May contribute to systemic conditions such as cardiovascular disease and arthritis.
Antibiotics and the Human Microbiome
Impact of Antibiotics
Antibiotics can disrupt the gut microbiome, affecting both target and non-target organisms.
Early Life Use: Increases risk of IBD and other dysbiosis-related disorders.
Resistant Pathogens: Clostridioides difficile can persist and proliferate following antibiotic therapy.
Fecal Transplants
Therapeutic Applications
Fecal transplants involve transferring microbiota from a healthy donor to a patient, restoring microbial balance.
Clinical Use: Effective in treating recurrent C. difficile infections.
Probiotics and Prebiotics
Definitions and Functions
Probiotics and prebiotics are used to support and restore healthy microbiota.
Probiotics: Live microorganisms that confer health benefits to the host. Common genera include Lactobacillus and Bifidobacterium.
Prebiotics: Indigestible carbohydrates that nourish beneficial gut bacteria, such as inulin and oligosaccharides.
Probiotic Inhibition of S. aureus
Mechanisms of Action
Probiotics can inhibit pathogenic bacteria through various mechanisms, including interference with quorum sensing and competitive exclusion.
Quorum Sensing: Probiotics may block signaling pathways used by Staphylococcus aureus to regulate virulence gene expression.
Example: Inhibition of the Agr system in S. aureus reduces toxin production and pathogenicity.